Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2015

Open Access 01-12-2015 | Epidemiology

SNPs and breast cancer risk prediction for African American and Hispanic women

Authors: Richard Allman, Gillian S. Dite, John L. Hopper, Ora Gordon, Athena Starlard-Davenport, Rowan Chlebowski, Charles Kooperberg

Published in: Breast Cancer Research and Treatment | Issue 3/2015

Login to get access

Abstract

For African American or Hispanic women, the extent to which clinical breast cancer risk prediction models are improved by including information on susceptibility single nucleotide polymorphisms (SNPs) is unknown, even though these women comprise increasing proportions of the US population and represent a large proportion of the world’s population. We studied 7539 African American and 3363 Hispanic women from the Women’s Health Initiative. The age-adjusted 5-year risks from the BCRAT and IBIS risk prediction models were measured and combined with a risk score based on >70 independent susceptibility SNPs. Logistic regression, adjusting for age group, was used to estimate risk associations with log-transformed age-adjusted 5-year risks. Discrimination was measured by the odds ratio (OR) per standard deviation (SD) and the area under the receiver operator curve (AUC). When considered alone, the ORs for African American women were 1.28 for BCRAT, and 1.04 for IBIS. When combined with the SNP risk score (OR 1.23), the corresponding ORs were 1.39 and 1.22. For Hispanic women the corresponding ORs were 1.25 for BCRAT, and 1.15 for IBIS. When combined with the SNP risk score (OR 1.39), the corresponding ORs were 1.48 and 1.42. There was no evidence that any of the combined models were not well calibrated. Including information on known breast cancer susceptibility loci provides approximately 10 and 19 % improvement in risk prediction using BCRAT for African Americans and Hispanics, respectively. The corresponding figures for IBIS are approximately 18 and 26 %, respectively.
Appendix
Available only for authorised users
Literature
13.
go back to reference Mavaddat N, Pharoah PD, Michailidou K et al (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 107(5):djv036. doi:10.1093/jnci/djv1036 [published online ahead of print 8 Apr 2015] CrossRefPubMed Mavaddat N, Pharoah PD, Michailidou K et al (2015) Prediction of breast cancer risk based on profiling with common genetic variants. J Natl Cancer Inst 107(5):djv036. doi:10.​1093/​jnci/​djv1036 [published online ahead of print 8 Apr 2015] CrossRefPubMed
19.
go back to reference StataCorp (2013) Stata statistical software, release 13. StataCorp LP, College Station StataCorp (2013) Stata statistical software, release 13. StataCorp LP, College Station
20.
go back to reference Dite GS, MacInnis RJ, Bickerstaffe A et al. (2015) Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev Submitted Dite GS, MacInnis RJ, Bickerstaffe A et al. (2015) Breast cancer risk prediction using clinical models and 77 independent risk-associated SNPs for women aged under 50 years: Australian Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev Submitted
21.
go back to reference Hopper JL (2015) Odds PER Adjusted standard deviation (OPERA): comparing strengths of associations for risk factors measured on different scales, and across diseases and populations. Am J Epidemiol 182(10):863–867CrossRefPubMed Hopper JL (2015) Odds PER Adjusted standard deviation (OPERA): comparing strengths of associations for risk factors measured on different scales, and across diseases and populations. Am J Epidemiol 182(10):863–867CrossRefPubMed
22.
go back to reference Amir E, Evans DG, Shenton A et al (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40(11):807–814PubMedCentralCrossRefPubMed Amir E, Evans DG, Shenton A et al (2003) Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 40(11):807–814PubMedCentralCrossRefPubMed
Metadata
Title
SNPs and breast cancer risk prediction for African American and Hispanic women
Authors
Richard Allman
Gillian S. Dite
John L. Hopper
Ora Gordon
Athena Starlard-Davenport
Rowan Chlebowski
Charles Kooperberg
Publication date
01-12-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3641-7

Other articles of this Issue 3/2015

Breast Cancer Research and Treatment 3/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine